(Q46956551)

26 December 2017

title

Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin (English)

1 reference

26 December 2017

1 reference

1 reference

A Soto González

1

1 reference

26 December 2017

D Bellido Guerrero

2

1 reference

26 December 2017

M Buño Soto

3

1 reference

26 December 2017

S Pértega Díaz

4

1 reference

26 December 2017

M Martinez-Olmos

5

1 reference

26 December 2017

O Vidal

6

1 reference

26 December 2017

publication date

22 February 2006

1 reference

26 December 2017

European Journal of Clinical Nutrition

published in

1 reference

26 December 2017

volume

60

1 reference

26 December 2017

issue

6

1 reference

26 December 2017

page(s)

802-809

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.ejcn.1602384

exact match

0 references

cites work

Disorders of iron metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Iron overload augments the development of atherosclerotic lesions in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Quantitative aspects of the reaction between insulin and insulin-binding antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Iron stores, blood donation, and insulin sensitivity and secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Association between C-reactive protein and features of the metabolic syndrome: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Serum ferritin and risk of the metabolic syndrome in U.S. adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Body iron stores in relation to risk of type 2 diabetes in apparently healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Differentiation between obesity and insulin resistance in the association with C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Free radicals and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Is type II diabetes mellitus a disease of the innate immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Recent advances in understanding haemochromatosis: a transition state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Relation between iron stores and non-insulin dependent diabetes in men: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

A relationship between serum ferritin and the insulin resistance syndrome is present in non-diabetic women but not in non-diabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Potential role of increased iron stores in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Coming of age of C-reactive protein: using inflammation markers in cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

Iron biology in immune function, muscle metabolism and neuronal functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

7 January 2021

Serum ferritin as a component of the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

7 January 2021

Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men--the Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

7 January 2021

Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

7 January 2021

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

7 January 2021

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

7 January 2021

Hemochromatosis associated with endothelial dysfunction: evidence for the role of iron stores in early atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

7 January 2021

C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

7 January 2021

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

7 January 2021

Increased serum ferritin is common in men with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

7 January 2021

Complement regulation in innate immunity and the acute-phase response: inhibition of mannan-binding lectin-initiated complement cytolysis by C-reactive protein (CRP)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

7 January 2021

Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602384

7 January 2021

Identifiers

DOI

10.1038/SJ.EJCN.1602384

1 reference

26 December 2017

PubMed ID

16493453

1 reference

26 December 2017